Elias Aboujaoude, MD, MA
Key Documents
Contact Information
-
Clinical Offices
Psychiatry 401 Quarry Rd Ste H2301A MC 5723 Stanford, CA 94305 Tel Work (650) 723-2423 Fax (650) 724-3144
- Academic Offices
Personal Information EmailNot for medical emergencies or patient use
Professional Overview
Clinical Focus
- Psychiatry
Professional Education
| Residency: | Stanford University School of Medicine CA (2002) |
| Board Certification: | Psychiatry, American Board of Psychiatry and Neurology (2004) |
| Internship: | UCSF Medical Center CA (1999) |
| Medical Education: | Stanford University School of Medicine CA (1998) |
Scientific Focus
Clinical Trials
- Duloxetine for the Treatment of Dysthymia Completed
- Memantine Augmentation in Obsessive-Compulsive Disorder Completed
- Study of SEP-225441 in Subjects with Generalized Anxiety Disorder No longer recruiting
Publications
- Problematic Internet use: an overview. World Psychiatry. 2010; (2): 85-90
- Double-blind study of dextroamphetamine versus caffeine augmentation for treatment-resistant obsessive-compulsive disorder. J Clin Psychiatry. 2009; (11): 1530-5
- Memantine augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial. J Clin Psychopharmacol. 2009; (1): 51-5
- Duloxetine treatment of dysthymia and double depression: an open-label trial. J Clin Psychiatry. 2007; (5): 761-5
- Escitalopram treatment of kleptomania: an open-label trial followed by double-blind discontinuation. J Clin Psychiatry. 2007; (3): 422-7
- Estimated prevalence of compulsive buying behavior in the United States. Am J Psychiatry. 2006; (10): 1806-12
Help